Funding
Turn ideas into impact
Show Me
Due: January 7, 2027
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-167
Due: January 7, 2027
National Cancer Institute’s Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
US $499,999
Type
Grant
Source
Federal
Opp Number
PAR-25-081
Due: January 7, 2027
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-256
Due: January 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-069
Due: January 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-070
Due: January 7, 2027
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
US $250,000
Type
Grant
Source
Federal
Opp Number
PAR-25-235
Due: January 7, 2027
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-159
Due: January 7, 2027
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-310
Due: January 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
US $1,515,000
Type
Grant
Source
Federal
Opp Number
PAR-25-025
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?